Buzz: Roche weighing up bid for Pacific Biosciences

Roche ($RHHBY) is reportedly considering continuing its sequencing dealmaking activity with a bid for Pacific Biosciences ($PACB). Reuters broke news of a preliminary approach by Roche, citing unnamed sources who said the deal is being held up by a disagreement about the price. If the deal goes ahead, it would represent a continuation of Roche's push to build out its sequencing unit, a strategy that has seen it acquire Genia Technologies, Kapa Biosystems and other companies in recent years. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.